The Use of CRISPR/Cas9 Technology in Engineering Chimeric Antigen Receptor (CAR)-T Cell Immunotherapy for the Treatment of Cancer in Brazil

被引：0
|
作者：
Carvalho, Julia [1 ]
Cupello, Mauricio [2 ]
Medina, Romulo [2 ]
机构：
[1] INCA, Rio De Janeiro, Brazil
[2] Unigranrio, Rio De Janeiro, Brazil
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2023年 / 23卷
关键词：
CAR-T; CRISPR/Cas9; Brazil; gene editing; universal CAR-T cells;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
CT-312
引用
收藏
页码：S525 / S526
页数：2
相关论文
共 50 条
  • [31] CRISPR/Cas9 technology for advancements in cancer immunotherapy: from uncovering regulatory mechanisms to therapeutic applications
    Feng, Xiaohang
    Li, Zhengxing
    Liu, Yuping
    Chen, Di
    Zhou, Zhuolong
    EXPERIMENTAL HEMATOLOGY & ONCOLOGY, 2024, 13 (01)
  • [32] CRISPR/Cas9: From Genome Engineering to Cancer Drug Discovery
    Luo, Ji
    TRENDS IN CANCER, 2016, 2 (06): : 313 - 324
  • [33] Concurrent transposon engineering and CRISPR/Cas9 genome editing of primary CLL-1 chimeric antigen receptor-natural killer cells
    Gurney, Mark
    O'Reilly, Eimear
    Corcoran, Sarah
    Brophy, Sarah
    Krawczyk, Janusz
    Otto, Neil M.
    Hermanson, David L.
    Childs, Richard W.
    Szegezdi, Eva
    O'Dwyer, Michael E.
    CYTOTHERAPY, 2022, 24 (11) : 1087 - 1094
  • [34] The Application of the CRISPR/Cas9 System in the Treatment of Hepatitis B Liver Cancer
    Lv, Wei
    Li, Tao
    Wang, Shanshan
    Wang, Huihui
    Li, Xuemei
    Zhang, Shubing
    Wang, Lianzi
    Xu, Yuanhong
    Wei, Wei
    TECHNOLOGY IN CANCER RESEARCH & TREATMENT, 2021, 20
  • [35] Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment q
    Xu, Xiaoyu
    Liu, Chang
    Wang, Yonghui
    Koivisto, Oliver
    Zhou, Junnian
    Shu, Yilai
    Zhang, Hongbo
    ADVANCED DRUG DELIVERY REVIEWS, 2021, 176
  • [36] Prospects and challenges of CRISPR/Cas9 gene-editing technology in cancer research
    Ning, Li
    Xi, Jiahui
    Zi, Yin
    Chen, Min
    Zou, Qingjian
    Zhou, Xiaoqing
    Tang, Chengcheng
    CLINICAL GENETICS, 2023, 104 (06) : 613 - 624
  • [37] Using CRISPR/Cas9 to Knock Out GM-CSF in CAR-T Cells
    Sterner, Rosalie M.
    Cox, Michelle J.
    Sakemura, Reona
    Kenderian, Saad S.
    JOVE-JOURNAL OF VISUALIZED EXPERIMENTS, 2019, (149):
  • [38] A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
    Ehsan Razeghian
    Mahyuddin K. M. Nasution
    Heshu Sulaiman Rahman
    Zhanna R. Gardanova
    Walid Kamal Abdelbasset
    Surendar Aravindhan
    Dmitry O. Bokov
    Wanich Suksatan
    Pooria Nakhaei
    Siavash Shariatzadeh
    Faroogh Marofi
    Mahboubeh Yazdanifar
    Somayeh Shamlou
    Roza Motavalli
    Farhad Motavalli Khiavi
    Stem Cell Research & Therapy, 12
  • [39] A deep insight into CRISPR/Cas9 application in CAR-T cell-based tumor immunotherapies
    Razeghian, Ehsan
    Nasution, Mahyuddin K. M.
    Rahman, Heshu Sulaiman
    Gardanova, Zhanna R.
    Abdelbasset, Walid Kamal
    Aravindhan, Surendar
    Bokov, Dmitry O.
    Suksatan, Wanich
    Nakhaei, Pooria
    Shariatzadeh, Siavash
    Marofi, Faroogh
    Yazdanifar, Mahboubeh
    Shamlou, Somayeh
    Motavalli, Roza
    Khiavi, Farhad Motavalli
    STEM CELL RESEARCH & THERAPY, 2021, 12 (01)
  • [40] Tropism-facilitated delivery of CRISPR/Cas9 system with chimeric antigen receptor-extracellular vesicles against B-cell malignancies
    Xu, Qian
    Zhang, Zheng
    Zhao, Lei
    Qin, Yun
    Cai, Haodong
    Geng, Zhe
    Zhu, Xiaojian
    Zhang, Wei
    Zhang, Yuanyuan
    Tan, Jiaqi
    Wang, Jue
    Zhou, Jianfeng
    JOURNAL OF CONTROLLED RELEASE, 2020, 326 : 455 - 467
12345